• Annual Report 2013  > 
  • Interactive Key Figures
    • Report Archive
    • EN
    • DE
    Annual Report
    2013
    • Investor Relations
      • 2013 at a Glance
      • Shaping the lab of the future
      • Letter to the Shareholders
      • Interview with CEO David Martyr
      • Markets and Market Position
      • Life Sciences Business
        • Selection of the current most important products and product groups
      • Partnering Business
        • Selection of the current most important products and product groups
      • Sustainability
    • Corporate Governance
      • 1 Group structure and shareholders
      • 2 Capital structure
      • 3 Board of Directors
      • 4 Management
      • 5 Content and method of determining compensation and stock option plans
      • 6 Shareholders’ participation rights
      • 7 Change of control and defense measures
      • 8 Statutory auditors
      • 9 Information policy
      • Compensation Report
    • Financial Report 2013
      • Chief Financial Officer’s Report
      • Five-year consolidated data
      • Consolidated financial statements
        • Consolidated statement of profit or loss
        • Consolidated statement of profit or loss and other comprehensive income
        • Consolidated balance sheet at December 31
        • Consolidated statement of cash flows
        • Consolidated statement of changes in equity
      • Notes to the consolidated financial statements
        • 1 Reporting entity
        • 2 Summary of significant accounting policies
        • 3 Scope of consolidation
        • 4 Segment information
        • 5 Operating expenses by nature
        • 6 Research and development
        • 7 Other operating income
        • 8 Financial result
        • 9 Earnings per share
        • 10 Employee benefits
        • 11 Income taxes
        • 12 Cash and cash equivalents
        • 13 Current loans and derivatives
        • 14 Trade accounts receivable
        • 15 Inventories
        • 16 Non-current financial assets
        • 17 Property, plant and equipment
        • 18 Intangible assets
        • 19 Bank liabilities and derivatives
        • 20 Deferred revenue
        • 21 Provisions
        • 22 Shareholders’ equity
        • 23 Foreign exchange rates
        • 24 Financial risk management (IFRS 7)
        • 25 Fair value measurement and disclosures
        • 26 Rental and lease commitments
        • 27 Contingent liabilities and encumbrance of assets
        • 28 Related parties
        • 29 Subsequent events
        • 30 Group risk management (disclosure according to Swiss law)
        • Auditors
      • Balance sheet of Tecan Group Ltd. at December 31
      • Income statement of Tecan Group Ltd.
      • Notes to the financial statements of Tecan Group Ltd.
        • 1 Reporting basis
        • 2 Investments in subsidiaries
        • 3 Treasury shares
        • 4 Provision for general business risks
        • 5 Shareholders’ equity
        • 6 Guarantees in favor of third parties
        • 7 Pledged assets
        • 8 Fire insurance value of property, plant and equipment
        • 9 Disclosures concerning the conduction of a risk assessment
        • 10 Compensation and loans granted to members of the Board of Directors and Management Board
        • 11 Share and option ownership of the Board of Directors and Management Board
        • Appropriation of available earnings
        • Auditors
      • The Tecan Share
      • Tecan locations
    Chart
    Create your own PDFǀ Interactive Key Figures

    Tecan Group Ltd.  Seestrasse 103   8708 Männedorf / Switzerland    T +41 44 922 81 11   investor(at)tecan.com